DGAP-News: MediClin AG: Business Development in FY 2011
(firmenpresse) - DGAP-News: MediClin AG / Key word(s): Final Results
MediClin AG: Business Development in FY 2011
22.03.2012 / 11:02
---------------------------------------------------------------------
Business Development of MediClin in FY 2011
Frankfurt am Main, March 22, 2012 - The Members of the Management Board of
MEDICLIN Aktiengesellschaft (MediClin) said at this year's balance sheet
press conference that they are satisfied with the results of FY 2011
especially against the background of new legal regulations, which don' t or
only limited allow to rise costs. 'The requirements for medical services
are increasing all the time, the willingness to honour more quality in the
treatments not. Therefore the solution can only be an integrated
cross-sector medical care, which allows an efficient treatment on a high
quality level', said Frank Abele, Chairman of the management Board..
Group sales increase by 1.3% to EUR 493.6 mill.
Group sales was EUR 493.6 mill., about EUR 6,4 mill. or 1.3 % above the
previous year's value. In the post-acute segment sales increased from EUR
275.2 mill. to EUR 279.3 mill. despite the slight decrease in occupancy. In
the acute segment, sales increased by EUR 0.6 mill., from EUR 200.3 mill.
to EUR 200.9 mill. Of the remaining sales increase totalling EUR 1.7 mill.,
EUR 0.8 mill. was derived from the nursing care business area. The service
business area, which is also assigned to the other activities segment,
recorded an increase in sales, too.
Group operating result (earnings before interest and taxes) was EUR 10.9
mill., which was EUR 6.0 mill. lower than the previous year. In the
post-acute segment, the segment result decreased von EUR 6.2 mill. to EUR
2,8 mill. and the acute segment result decreased from EUR 18.2 mill. to EUR
15.2 mill. Despite the rise in sales, the cost of raw materials and
consumables used was EUR 110.4 mill., nearly on the same level as the
previous year. Personnel costs increased by EUR 11.6 mill. up to EUR 278.6
mill. compared to the previous year.
A total of EUR 29.9 mill. was invested in 2011, or EUR 6.6 mill. more than
in the previous year. A further EUR 15.9 mill. was spent on maintenance. On
the 2011 balance sheet date, with liquid funds of EUR 41.3 mill., MediClin
had enough cash and cash equivalents to finance further growth.
Capacity expansion in the segments to secure future internal growth
In the post-acute segment the bed capacity was significantly increased in
neurology and psychosomatics as a result of higher demand. The expansion of
the service range in these specialist medical fields reflects corporate
strategy to concentrate on specific areas that correspond to
.
growing demand. The bed capacity in the acute segment was also expanded
over the course of the financial year. In the coming years, a rising
occupancy rates for these additional capacities is expected.
Outlook
In 2012, MediClin will continue on the path that it has embarked upon -
providing cross sector, integrated, patient-focused care that is close to
patients' homes. Opportunities sees MediClin in the shareholding of the
Asklepios Group. The Management Board anticipates additional growth
potential as overlaps in the service range only exist at a few locations.
The refinancing of existing loan obligations totalling EUR 61.4 mill. will
have a positive effect in the 2012 financial year. Accordingly, updated
interest rates lead to expectations of a better financialresult from 2012
onwards.
Overall, should the framework conditions in the industry and the referral
practices of coverage providers not change drastically in 2012, the
Management Board expects an increase in sales and a solid earnings
performance for the current financial year.
The annual report 2011 is available on www.mediclin.de in German and
English.
Key figures - yoy comparison and quarterly development Group and segments
/Über die MediClin AG (Ticker: MED; WKN: 659 510)
MediClin AG is a nation-wide clinic operator and large provider of services
in the area of Psycho- and Neuro-sciences as well as Orthopaedic. With 34
clinics and 7 nursing care facilities and 11 Medizinische
Versorgungs-zentren (medical care units) in 11 federal states MediClin has
a total capacity of approximately 8,100 beds. MediClins' facilities include
acute care clinics, i.e., general hospitals, special treatment facilities,
specialised hospitals and clinics for post-acute treatment and medical
rehabilitation. MediClin
has approximately 8,300 employees.
Important notice:
This press release includes future-oriented statements which are based on
assumptions and estimates. While MediClin AG is of the opinion that these
assumptions and estimates are correct, the actual future developments and
actual future results may deviate from these assumptions and estimates due
to the impact of various factors such as changes in the economic conditions
in Germany, legal changes concerning the health system, changes relating to
cost providers' expense behaviour. MediClin does not assume liability and
gives no warranty that future developments and the income actually achieved
in the future will comply with the assumptions and estimates stated in this
press release.
End of Corporate News
---------------------------------------------------------------------
22.03.2012 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: MediClin AG
Okenstraße 27
77652 Offenburg
Germany
Phone: +49 (0)781 488-189
Fax: +49 (0)781 488-184
E-mail: alexandra.muehr(at)mediclin.de
Internet: www.mediclin.de
ISIN: DE0006595101
WKN: 659510
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, Hamburg, München,
Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------
161795 22.03.2012
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 22.03.2012 - 11:02 Uhr
Sprache: Deutsch
News-ID 127379
Anzahl Zeichen: 10284
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 196 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: MediClin AG: Business Development in FY 2011"
steht unter der journalistisch-redaktionellen Verantwortung von
MediClin AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
